Evidence map›Paper›PMID 22276156›Full record

ArticlePloS one2012

Imaging the impact of chemically inducible proteins on cellular dynamics in vivo.

Hon S Leong, Michael M Lizardo, Amber Ablack, Victor A McPherson, Thomas J Wandless, Ann F Chambers, John D Lewis

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Cyclin A2, a novel regulator of EMT.Cellular and molecular life sciences : CMLS · 2014
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Hon S LeongTranslational Prostate Cancer Research Group, London Regional Cancer Program, London, Ontario, Canada.
Michael M Lizardo
Amber Ablack
Victor A McPherson
Thomas J Wandless
Ann F Chambers
John D Lewis
Western University · CAStanford University · US

Funding

Novel Molecules as In Vivo Biological ProbesR01GM073046 · NIGMS · STANFORD UNIVERSITY · PI WANDLESS, THOMAS JAMES · 2006 to 2017
$3.6M
CIHR 016506NIGMS NIH HHS R01 GM073046
6 · The paper itself

Abstract

The analysis of dynamic events in the tumor microenvironment during cancer progression is limited by the complexity of current in vivo imaging models. This is coupled with an inability to rapidly modulate and visualize protein activity in real time and to understand the consequence of these perturbations in vivo. We developed an intravital imaging approach that allows the rapid induction and subsequent depletion of target protein levels within human cancer xenografts while assessing the impact on cell behavior and morphology in real time. A conditionally stabilized fluorescent E-cadherin chimera was expressed in metastatic breast cancer cells, and the impact of E-cadherin induction and depletion was visualized using real-time confocal microscopy in a xenograft avian embryo model. We demonstrate the assessment of protein localization, cell morphology and migration in cells undergoing epithelial-mesenchymal and mesenchymal-epithelial transitions in breast tumors. This technique allows for precise control over protein activity in vivo while permitting the temporal analysis of dynamic biophysical parameters.

Indexed as

AnimalsBirdsBreast NeoplasmsCadherinsCell Line, TumorDiagnostic ImagingEpithelial-Mesenchymal TransitionFemaleHumansMicroscopy, ConfocalMicroscopy, FluorescenceMorpholinesTransplantation, HeterologousVimentinCadherinsMorpholinesShield-1 compoundVimentin

Identifiers

PMID22276156
PMCPMC3261888
OpenAlexW2057910680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.